Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
3.190
-0.050 (-1.54%)
At close: Jul 25, 2025, 4:00 PM
3.200
+0.010 (0.31%)
After-hours: Jul 25, 2025, 7:56 PM EDT
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $131.06 million as of July 25, 2025. Its market cap has increased by 85.12% in one year.
Market Cap
131.06M
Enterprise Value
117.78M
1-Year Change
85.12%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $131.06M, a decrease of -19.53%. That is a compound annual growth rate of -5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 131.06M | 200.82% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
| May 7, 2021 | 162.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.19B |
| Johnson & Johnson | 406.87B |
| AbbVie | 336.59B |
| Novo Nordisk | 309.02B |
| UnitedHealth Group | 265.35B |
| Novartis AG | 227.08B |
| AstraZeneca | 224.54B |
| Abbott Laboratories | 218.92B |